Clinical Efficacy and Adverse Effects of Antibiotics Used to Treat Mycobacterium abscessus Pulmonary Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Efficacy and Adverse Effects of Antibiotics Used to Treat Mycobacterium abscessus Pulmonary Disease

Published:2019-08-23 Issue: Volume:10 Page:
ISSN:1664-302X
Container-title:Frontiers in Microbiology
language:
Short-container-title:Front. Microbiol.

Author:

Chen Jianhui,Zhao Lan,Mao Yanhua,Ye Meiping,Guo Qi,Zhang Yongjie,Xu Liyun,Zhang Zhemin,Li Bing,Chu Haiqing

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Microbiology (medical),Microbiology

Reference35 articles.

1. Clinical efficacy and adverse effects of antibiotics used to treat Mycobacterium abscessus pulmonary disease.;Chen;BioRxiv,2019

2. Antibiotic susceptibility of diverse Mycobacterium abscessus complex strains in new South Wales, Australia.;Chua;Pathology,2015

3. Mycobacterium abscessus and antibiotic resistance: same as it ever was.;Griffith;Clin. Infect. Dis.,2019

4. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.;Griffith;Am. J. Respir. Crit. Care Med.,2007

5. The Clarithromycin susceptibility genotype affects the treatment outcome of patients with Mycobacterium abscessus lung disease.;Guo;Antimicrob. Agents Chemother.,2018

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of novel double-reporter strains of Mycobacterium abscessus for drug discovery: a study in mScarlet;Microbiology Spectrum;2024-08-27

2. Efflux pumps and membrane permeability contribute to intrinsic antibiotic resistance inMycobacterium abscessus;2024-08-24

3. An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection;Antimicrobial Agents and Chemotherapy;2024-08-07

4. A Quality by Design Approach for Optimizing Solid Lipid Nanoparticles of Bedaquiline for Improved Product Performance;AAPS PharmSciTech;2024-07-01

5. Triggerable biomaterials‐based osteomyelitis theranostics;BMEMat;2024-04-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3